Sep 22, 2026 4 0
Uploaded by Cart
Favorite
Share
More Options
10
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers - a phase I clinical trial_Page 1

Open in WPS to view all 10 pages